HER2 Support Group Forums - View Single Post - FDA grants accelerated approval of Perjeta for people with HER2-positive early stage

News · 10-02-2013, 05:00 AM

The U.S. Food and Drug Administration granted accelerated approval of a Perjeta- (pertuzumab) regimen for neoadjuvant treatment (use before surgery) in people with high-risk, HER2-positive early stage breast cancer.

More...

10-02-2013, 05:00 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,104	FDA grants accelerated approval of Perjeta for people with HER2-positive early stage The U.S. Food and Drug Administration granted accelerated approval of a Perjeta- (pertuzumab) regimen for neoadjuvant treatment (use before surgery) in people with high-risk, HER2-positive early stage breast cancer. More...